Summary.
Treatment with a single oral dose of (−)-deprenyl (selegiline) before DSP-4 administration could dose-dependently decrease the noradrenaline (NA) depleting effect of the toxin in mouse hippocampus. The maximum protective effect was achieved at as low oral dose as 0.25 mg/kg. Pre-treatment with the same doses of the main metabolites of (−)-deprenyl: (−)-amphetamine and (−)-methylamphetamine provided a weaker attenuation of DSP-4 induced NA depletion, than the parent compound. The selective noradrenergic toxin DSP-4, which depletes NA in nerve terminals originating from the locus coeruleus, is presumably metabolised by CYP-450 enzymes. Continuous administration of low, by themselves non-toxic doses of DSP-4 resulted in the cumulation of its NA depleting effect.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received March 12, 2001; accepted June 1, 2001
Rights and permissions
About this article
Cite this article
Haberle, D., Szökö, É., Halász, A. et al. The effect of low oral doses of (−)-deprenyl and its metabolites on DSP-4 toxicity. J Neural Transm 108, 1239–1247 (2001). https://doi.org/10.1007/s007020100002
Issue Date:
DOI: https://doi.org/10.1007/s007020100002